NCT06668519

Brief Summary

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2024Dec 2027

Study Start

First participant enrolled

September 25, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 30, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 31, 2024

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

3.3 years

First QC Date

October 30, 2024

Last Update Submit

March 24, 2026

Conditions

Keywords

neurodevelopmental diseasesmagnetoencephalographypediatric

Outcome Measures

Primary Outcomes (1)

  • Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children

    Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria

    3 years

Study Arms (2)

children with neurodevelopmental diseases

Other: Magnetoencephalography

healthy children

Other: Magnetoencephalography

Interventions

Magnetoencephalography

children with neurodevelopmental diseaseshealthy children

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children aged 1 month to 18 years old

You may qualify if:

  • aged 1 month-18 years old (date of investigate minus date of birth)
  • epilepsy
  • intracranial tumors
  • cerebrovascular diseases
  • autism
  • mental retardation
  • ADHD
  • tic disorder
  • neuropsychiatric disorders

You may not qualify if:

  • Unable to cooperate with the exam of MEG

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Fudan University

Shanghai, 201102, China

RECRUITING

MeSH Terms

Conditions

EpilepsyBrain NeoplasmsCerebrovascular DisordersAutistic DisorderAttention Deficit Disorder with HyperactivityTic DisordersIntellectual DisabilityDevelopmental Disabilities

Interventions

Magnetoencephalography

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsVascular DiseasesCardiovascular DiseasesAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersAttention Deficit and Disruptive Behavior DisordersMovement DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMagnetometryInvestigative Techniques

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2024

First Posted

October 31, 2024

Study Start

September 25, 2024

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations